Aurora Italia
About Aurora Italia
Italian arm of Aurora Cannabis supplying pharmaceutical-grade medical cannabis to the Italian market through authorised distribution channels.
Key Facts
- 1Parent company Aurora Cannabis is one of Canada's largest licensed producers
- 2Supplies Italian pharmacies via partnerships with local pharmaceutical distributors
Latest News
Aurora Cannabis Pushes Global Medical Expansion Across Three Continents
ACB launches new medical cannabis products in Canada, Europe and Australia as company pivots toward international growth strategy
Aurora Cannabis Stock Analysis: Recovery Play or Value Trap?
ACB trades at deep discount but faces execution challenges in competitive market
Major Cannabis Stocks Plunge on Rescheduling Reality Check
TLRY, CGC, ACB, CRON, and OGI tumble as investors reassess limited impact of federal cannabis reclassification on Canadian operators and market fundamentals.
Cannabis Stocks Plunge as Rescheduling Optimism Fades
Major cannabis operators including TLRY, CGC, and ACB tumble as investors reassess limited impact from federal reclassification prospects.
Aurora Cannabis Decline Pressures TSX Smallcap Index Performance
ACB's continued weakness weighs on Canadian small-cap benchmarks as cannabis sector struggles persist through 2024 trading sessions.
Frequently Asked Questions
What products does Aurora supply in Italy?
GMP-certified dried cannabis flower and standardised cannabis oil preparations for medical use.
Is a prescription required?
Yes, all Aurora Italia products require a physician's prescription and are dispensed only through pharmacies.
More Cannabis Companies in Milan
Cannabis Laws
Products
- Medical cannabis flower
- Standardised cannabis oils
Specialties
Company Details
- Type
- Medical & Pharma
- Location
- Milan, Italy
- Founded
- 2019
- Publicly Traded
- Yes
- Ticker
- TSX:ACB